Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
British Journal of Pharmacology|October 22, 2025
History, pharmacology and therapeutic mechanisms of 3,4-methylenedioxymethamphetamine (MDMA)Austen B Casey, Boris D HeifetsACS Chemical Neuroscience|April 4, 2017
Classics in Chemical Neuroscience: AripiprazoleAusten B Casey, Clinton E CanalBiochemical Pharmacology|April 5, 2022
"Selective" serotonin 5-HT2A receptor antagonistsAusten B Casey, Meng Cui, Raymond G Booth, et al.British Journal of Pharmacology|November 27, 2021
A new class of 5-HT2A /5-HT2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2-aminotetralinsAusten B Casey, Munmun Mukherjee, Ryan P McGlynn, et al.ACS Pharmacology & Translational Science|June 23, 2020
(S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum DisorderJessica L Armstrong, Austen B Casey, Tanishka S Saraf, et al.Nature Communications|January 21, 2026
No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of painNicholas S Gregory, Tyler E Girard, Akila Ram, et al.Biorxiv : the Preprint Server for Biology|July 17, 2025
Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain modelsNicholas S Gregory, Tyler E Girard, Akila Ram, et al.Biorxiv : the Preprint Server for Biology|March 18, 2024
Opioid receptor expressing neurons of the central amygdala gate behavioral effects of ketamine in miceMatthew B Pomrenze, Sam Vaillancourt, Pierre Llorach, et al.Bioorganic & Medicinal Chemistry|December 29, 2019
Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT1A and 5-HT7 G protein-coupled receptor affinity, 3D-QSAR and molecular modelingCharles K Perry, Austen B Casey, Daniel E Felsing, et al.Biological Psychiatry|May 7, 2025
Ketamine evokes acute behavioral effects via μ-opioid receptor expressing neurons of the central amygdalaMatthew B Pomrenze, Sam Vaillancourt, Pierre Llorach, et al.Pageof 2